Anna Zygogianni

1.1k total citations
86 papers, 722 citations indexed

About

Anna Zygogianni is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Anna Zygogianni has authored 86 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 29 papers in Pulmonary and Respiratory Medicine and 21 papers in Surgery. Recurrent topics in Anna Zygogianni's work include Advanced Radiotherapy Techniques (21 papers), Head and Neck Cancer Studies (16 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Anna Zygogianni is often cited by papers focused on Advanced Radiotherapy Techniques (21 papers), Head and Neck Cancer Studies (16 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Anna Zygogianni collaborates with scholars based in Greece, United Kingdom and Qatar. Anna Zygogianni's co-authors include Vassilis Kouloulias, John Kouvaris, George Kyrgias, Nikolaos Kelekis, Christos Antypas, Petros Karakitsos, A. Psyrri, Kalliopi Platoni, Kyriaki Mystakidou and Eleni Tsilika and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and British Journal of Cancer.

In The Last Decade

Anna Zygogianni

80 papers receiving 713 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Zygogianni Greece 15 212 161 151 129 109 86 722
Jonathan Klein United States 14 199 0.9× 247 1.5× 215 1.4× 154 1.2× 168 1.5× 40 900
Li‐Min Sun Taiwan 18 256 1.2× 181 1.1× 279 1.8× 134 1.0× 121 1.1× 45 856
Mark Farrugia United States 15 172 0.8× 277 1.7× 161 1.1× 117 0.9× 88 0.8× 69 745
Christopher Wynne New Zealand 15 295 1.4× 147 0.9× 152 1.0× 73 0.6× 126 1.2× 35 740
Ajeet Kumar Gandhi India 16 216 1.0× 190 1.2× 269 1.8× 101 0.8× 90 0.8× 102 1.1k
Sung Jun United States 16 311 1.5× 378 2.3× 111 0.7× 153 1.2× 127 1.2× 84 788
Nora Sundahl Belgium 16 321 1.5× 275 1.7× 213 1.4× 69 0.5× 67 0.6× 39 863
Moon‐Sing Lee Taiwan 19 225 1.1× 243 1.5× 223 1.5× 212 1.6× 62 0.6× 65 961
Seema Gulia India 14 310 1.5× 148 0.9× 242 1.6× 47 0.4× 81 0.7× 51 813
Shaleen Kumar India 15 105 0.5× 230 1.4× 190 1.3× 73 0.6× 191 1.8× 53 695

Countries citing papers authored by Anna Zygogianni

Since Specialization
Citations

This map shows the geographic impact of Anna Zygogianni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Zygogianni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Zygogianni more than expected).

Fields of papers citing papers by Anna Zygogianni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Zygogianni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Zygogianni. The network helps show where Anna Zygogianni may publish in the future.

Co-authorship network of co-authors of Anna Zygogianni

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Zygogianni. A scholar is included among the top collaborators of Anna Zygogianni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Zygogianni. Anna Zygogianni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Syrigos, Nikolaos, Anna Zygogianni, Ioannis Georgakopoulos, et al.. (2024). Comprehensive 3DCRT Hypofractionated Radiotherapy Schedule for Localized Prostate Adenocarcinoma in the Era of IMRT: Dosimetric and Endoscopic Analysis. Cancers. 16(6). 1192–1192. 1 indexed citations
4.
Georgakopoulos, Ioannis, et al.. (2024). Lymphopenia is an adverse prognostic factor in rectal adenocarcinoma patients receiving long-course chemoradiotherapy. Radiation Oncology Journal. 42(4). 263–272.
5.
Koutsoukos, Konstantinos, Roubini Zakopoulou, Kimon Tzannis, et al.. (2024). 1961O Nivolumab plus chemoradiotherapy in patients with non-metastatic muscle-invasive bladder cancer (nmMIBC), not undergoing cystectomy: A phase II, randomized study by the Hellenic GU Cancer Group. Annals of Oncology. 35. S1133–S1134. 2 indexed citations
6.
Mulita, Admir, et al.. (2024). Lymphopenia Induced by Different Neoadjuvant Chemo-Radiotherapy Schedules in Patients with Rectal Cancer: Bone Marrow as an Organ at Risk. Current Oncology. 31(10). 5774–5788. 1 indexed citations
7.
Kouloulias, Vassilis, et al.. (2023). Current status of locally advanced rectal cancer therapy and future prospects. Critical Reviews in Oncology/Hematology. 186. 103992–103992. 15 indexed citations
8.
Platoni, Kalliopi, et al.. (2023). Prostate Cancer Stem Cells: Biology and Treatment Implications. International Journal of Molecular Sciences. 24(19). 14890–14890. 11 indexed citations
9.
Zygogianni, Anna, et al.. (2023). Anti-Tumor Immunity and Preoperative Radiovaccination: Emerging New Concepts in the Treatment of Breast Cancer. International Journal of Molecular Sciences. 24(11). 9310–9310. 1 indexed citations
10.
Platoni, Kalliopi, et al.. (2023). Immune Response and Immune Checkpoint Molecules in Patients with Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy: A Review. Current Issues in Molecular Biology. 45(5). 4495–4517. 4 indexed citations
11.
12.
Tsilika, Eleni, et al.. (2023). Psychometric Properties of the Greek Version of Demoralization Scale-II (DS-II) in Patients with Cancer. Journal of Caring Sciences. 12(2). 103–109. 5 indexed citations
13.
Protopapa, Maria Lucia, et al.. (2023). Surface-Guided Radiotherapy: Can We Move on from the Era of Three-Point Markers to the New Era of Thousands of Points?. Bioengineering. 10(10). 1202–1202. 4 indexed citations
14.
Kakkos, Iοannis, P. Karaiskos, Vassilis Kouloulias, et al.. (2022). Early Prediction of Planning Adaptation Requirement Indication Due to Volumetric Alterations in Head and Neck Cancer Radiotherapy: A Machine Learning Approach. Cancers. 14(15). 3573–3573. 9 indexed citations
15.
Zygogianni, Anna, et al.. (2022). Is anti-PD-1 immunotherapy a means for post-irradiation tumor clearance in head and neck cancer?. Medical Oncology. 39(12). 186–186. 1 indexed citations
16.
Kouloulias, Vassilis, et al.. (2021). The need for a dose constraint in hip prosthesis to minimize later hip dysfunction. A retrospective analysis of relevant cases. Medical dosimetry. 46(3). 279–282. 1 indexed citations
17.
18.
Kyrgias, George, et al.. (2013). Hidradenocarcinoma of the temporal area successfully treated with concomitant electrochemotherapy and radiotherapy. Head & Neck Oncology. 5(2). 14. 11 indexed citations
19.
Kouloulias, Vassilis, Anna Zygogianni, Kalliopi Platoni, et al.. (2013). Evaluation of acute/late toxicity and local recurrence in Τ1-Τ2 glottic carcinoma treated with accelerated hypofractionated 3D-conformal external beam radiotherapy (3D-CRT). Radiology and Oncology. 47(2). 185–191. 2 indexed citations
20.
Guida, Agostino, John Kouvaris, Ioannis Georgakopoulos, et al.. (2012). Efficacy, cosmesis and skin toxicity in a hypofractionated irradiation schedule for cutaneous basal cell carcinoma of the head and neck area.. Head & Neck Oncology. 4(5). 88. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathan Klein Breakdown of academic impact, for papers by Li‐Min Sun Breakdown of academic impact, for papers by Mark Farrugia Breakdown of academic impact, for papers by Christopher Wynne Breakdown of academic impact, for papers by Ajeet Kumar Gandhi Breakdown of academic impact, for papers by Sung Jun Breakdown of academic impact, for papers by Nora Sundahl Breakdown of academic impact, for papers by Moon‐Sing Lee Breakdown of academic impact, for papers by Seema Gulia Breakdown of academic impact, for papers by Shaleen Kumar
Rankless by CCL
2026